News

The Pulmonary Fibrosis Foundation (PFF) today announced that 59 pulmonary fibrosis (PF) support groups nationwide received grants from the 2019 Leanne Storch Support Group Fund. The Fund is sponsored by Boehringer Ingelheim and Genentech, a Roche company. Named for the PFF’s former executive director who was diagnosed with PF in 2003, the Leanne Storch Support Group Fund honors her passion for supporting those affected by the disease.

The Pulmonary Fibrosis Foundation announced the launch of PRECISIONS, a study that aims to transform the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), by moving it into the era of precision medicine.

Commit To Drive Disease Awareness, Expand Research And Patient Advocacy

Pulmonary Fibrosis Foundation’s Care Center Network Expands To 33 States

The Pulmonary Fibrosis Foundation announced David Lederer, M.D., M.S., Senior Medical Advisor for Education and Awareness, was honored with the John W. Walsh PAR Award for Excellence on Sunday, May 19, at the American Thoracic Society International Conference in Dallas.

The Pulmonary Fibrosis Foundation announced data from four studies exploring the symptoms and treatments associated with this progressive and debilitating form of lung disease.